# Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)

Study · id `cardio:ct-nct01820078` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01820078](<https://clinicaltrials.gov/study/NCT01820078>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01820078

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 127 participants.

## Technical summary

Registry record NCT01820078. Randomized; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2013-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 127 participants (enrolled count; ClinicalTrials.gov record NCT01820078, source copy `cardio:ctgov-nct01820078-2013-11-28`, retrieved 2026-10-26)
- Start date: 2012-05 (registry gives no type) (ClinicalTrials.gov record NCT01820078, source copy `cardio:ctgov-nct01820078-2013-11-28`, retrieved 2026-10-26)
- Primary completion: 2013-09 (actual) (ClinicalTrials.gov record NCT01820078, source copy `cardio:ctgov-nct01820078-2013-11-28`, retrieved 2026-10-26)
- Completion: 2013-12 (anticipated) (ClinicalTrials.gov record NCT01820078, source copy `cardio:ctgov-nct01820078-2013-11-28`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT01820078, source copy `cardio:ctgov-nct01820078-2013-11-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01820078-2013-11-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)
- Acronym: PALIFE
- Condition: Chronic Kidney Disease, Unspecified
- Intervention (Drug): Experimental arm
- Intervention (Other): Comparator Arm
- Lead sponsor: Fundación Renal Iñigo Alvarez De Toledo
- Lead sponsor class: OTHER
- Collaborator: Effice Servicios Para la Investigacion S.L.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: a1cbcbea490a99e40a558ce6ccbb7c09a06d3ba2b28b99a92ce7fbb03abd4a18
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
